Insmed Incorporated (NASDAQ: INSM) stock fell -0.23% on Monday to $26.55 against a previous-day closing price of $26.61. With 0.97 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.31 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $26.79 whereas the lowest price it dropped to was $26.04. The 52-week range on INSM shows that it touched its highest point at $27.59 and its lowest point at $16.04 during that stretch. It currently has a 1-year price target of $42.23. Beta for the stock currently stands at 1.53.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of INSM was up-trending over the past week, with a rise of 0.19%, but this was up by 20.85% over a month. Three-month performance surged to 32.75% while six-month performance rose 52.41%. The stock gained 9.80% in the past year, while it has gained 32.88% so far this year. A look at the trailing 12-month EPS for INSM yields -5.24 with Next year EPS estimates of -4.41. For the next quarter, that number is -1.12. This implies an EPS growth rate of -0.90% for this year and 15.00% for next year.
Float and Shares Shorts:
At present, 143.80 million INSM shares are outstanding with a float of 141.93 million shares on hand for trading. On Aug 30, 2023, short shares totaled 12.44 million, which was 8.65% higher than short shares on Jul 30, 2023. In addition to Mr. William H. Lewis J.D., M.B.A. as the firm’s Pres, CEO & Chairman, Ms. Sara M. Bonstein M.B.A., MBA serves as its Chief Financial Officer.
Through their ownership of 109.45% of INSM’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 56.84% of INSM, in contrast to 45.49% held by mutual funds. Shares owned by individuals account for 3.36%. As the largest shareholder in INSM with 8.99% of the stake, The Vanguard Group, Inc. holds 12,929,276 shares worth 12,929,276. A second-largest stockholder of INSM, T. Rowe Price Associates, Inc., holds 9,932,137 shares, controlling over 6.91% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in INSM, holding 9,113,311 shares or 6.34% stake. With a 3.05% stake in INSM, the T Rowe Price New Horizons Fund is the largest stakeholder. A total of 4,379,135 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.97% of INSM stock, is the second-largest Mutual Fund holder. It holds 4,268,181 shares valued at 93.43 million. Vanguard Small Cap Index Fund holds 2.47% of the stake in INSM, owning 3,556,960 shares worth 77.86 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, INSM reported revenue of $65.22M and operating income of -$88.32M. The EBITDA in the recently reported quarter was -$91.22M and diluted EPS was -$0.80.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for INSM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With INSM analysts setting a high price target of $52.00 and a low target of $33.00, the average target price over the next 12 months is $41.92. Based on these targets, INSM could surge 95.86% to reach the target high and rise by 24.29% to reach the target low. Reaching the average price target will result in a growth of 57.89% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded INSM stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 740 shares were sold. The number of buy transactions has increased to 34 while that of sell transactions has risen to 41 over the past year. The total number of shares bought during that period was 820,192 while 127,782 shares were sold.